TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5/20/25 16:35 | 5/16/25 | HCWB | Hcw Biologics Inc. | DE | Health | Drug | Pharmaceutical Preparations | Wong Hing C | FL | DOT | CEO | P | 60 | 7.45 | 0 | 8 | 2 | 502 | D | ||||||||||||||
5/9/25 17:32 | 5/8/25 | HCWB | Hcw Biologics Inc. | DE | Health | Drug | Pharmaceutical Preparations | Wong Hing C | FL | DOT | CEO | P.d | 2,405 | 26.00 | 0 | 93 | 23 | 494 | D | ||||||||||||||
9/18/23 16:36 | 9/14/23 | HCWB | Hcw Biologics Inc. | DE | Health | Drug | Pharmaceutical Preparations | Wong Hing C | FL | DO | CEO | P | 4 | 2.08 | 0 | 2 | 0 | 15,315 | D | ||||||||||||||
6/2/23 20:25 | 6/1/23 | HCWB | Hcw Biologics Inc. | DE | Health | Drug | Pharmaceutical Preparations | Wong Hing C | FL | DO | CEO | P.m | 3 | 1.58 | 0 | 2 | 0 | 15,313 | D | ||||||||||||||
6/1/23 17:47 | 5/30/23 | HCWB | Hcw Biologics Inc. | DE | Health | Drug | Pharmaceutical Preparations | Wong Hing C | FL | DO | CEO | P.m | 8 | 1.55 | 0 | 5 | 0 | 15,311 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |